News

Recent graduate, Fangli Geng, of the Decision Science track of the Health Policy PhD program, received the 2025 AcademyHealth Outstanding Dissertation Award. The award recognizes Geng’s

CHDS faculty Jagpreet Chhatwal is member of a newly formed ISPOR Working Group on Generative Artificial Intelligence (GenAI), which published its first report on opportunities, challenges, and policy

Decision analytic models are a foundational tool in health economics, shaping how we evaluate the costs and benefits of interventions. As discussed by Jeremy Labrecque and Maurice Korf

How to integrate environmental damage, including health impacts, into assessments of economic activities was the topic of a recent OECD workshop on environmental impact valuation.

Michael R. Eber successfully defended his dissertation, Essays on Consumer Preferences in Health, as part of the Decision Science Track of the PhD Program in Health Policy at Harvard University.

Lily Hsieh, doctoral student in Health Policy concentrating in Decision Science, successfully defended her thesis, The Synergy of Real-World Evidence, Transportability, and

While randomized trials (RCTs) are required for approval of new medications, these generally exclude pregnant participants. In a CHDS seminar, Alyssa Bilinski discussed a decision-analytic

CHDS Faculty Jane Kim and Nicole Campos were awarded funds for the 2025 cycle of the Lemann Brazil Research Fund, which supports research projects on current issues facing Brazil.

CHDS Faculty Ankur Pandya, Uwe Siebert, and Myriam Hunink joined colleagues in recommending directed acyclic graphs (DAGs) in Decision-Analytic Modeling in a recent Medical Decision Making

Maria (Myriam) Hunink, MD, PhD was honored for her career achievements at a symposium and celebratory event held at the Nieuwe Instituut, Rotterdam, the Netherlands last month.